![]()
yahoo | Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering - Yahoo Finance |
yahoo | Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering - Yahoo Finance |
yahoo | Avenue Therapeutics Prices $2.0 Million Underwritten Public Offering of Common Stock - Yahoo Finance |
yahoo | Avenue Therapeutics Announces Closing of Public Offering of Common Stock - Yahoo Finance |
yahoo | Avenue Therapeutics Receives Interim Response to its Formal Dispute Resolution Request from U.S. Food and Drug Administration Office of New Drugs - Yahoo Finance |
yahoo | What's in Store for Perrigo This Earnings Season? |
yahoo | VITUS to Hurt Chemed Q1 Earnings, Roto-Rooter to Aid |
yahoo | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avenue Therapeutics, Inc. - ATXI |
yahoo | Avenue Therapeutics Sees Hammer Chart Pattern: Time to Buy? |
fool | Why Fortress Biotech Stock Is Sinking Today |
fool | Why Fortress Biotech Stock Jumped Today |
zacks | Avenue Therapeutics Misses Earnings Estimates in Q2 |
zacks | What's in Store for Avenue Therapeutics in Q2 Earnings? |
zacks | Avenue Therapeutics, Inc. Dips More Than Broader Markets: What You Should Know |
nasdaq | Avenue Therapeutics, Inc. Stock Sinks As Market Gains: What You Should Know |
zacks | Pacira Provides Preliminary Results for Second Quarter |
zacks | Avenue Therapeutics, Inc. Upgraded to Strong Buy: Here's What You Should Know |
zacks | Aclaris Gets FDA Nod to Start Investigator-led Coronavirus Study |
zacks | NGM Biopharmaceuticals Soars: Stock Adds 7.8% in Session |
zacks | Is Avenue Therapeutics Outperforming Other Medical Stocks This Year? |
yahoo | Zacks.com featured highlights include: Avenue Therapeutics, Calix, ChannelAdvisor and Magic Software Enterprises |
zacks | Flexion Soars: Stock Adds 6.6% in Session |
yahoo | Hedge Funds Watching Avenue Therapeutics, Inc. From Afar |
zacks | How Avenue Stock Stands Out in a Strong Industry |
